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Abstract
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We present here the crystal structures of fosfomycin resistance protein (FomA) complexed with
MgATP, with ATP and fosfomycin, with MgADP and fosfomycin vanadate, with MgADP and the
product of the enzymatic reaction, fosfomycin monophosphate, and with ADP at 1.87, 1.58, 1.85,
1.57, and 1.85 Å resolution, respectively. Structures of these complexes that approximate different
reaction steps allowed us to distinguish the catalytically active conformation of ATP and to
reconstruct the model of the MgATP·fosfomycin complex. According to the model, the
triphosphate tail of the nucleotide is aligned toward the phosphonate moiety of fosfomycin, in
contast to the previously published MgAMPPNP complex, with the attacking fosfomycin oxygen
positioned 4 Å from the γ-phosphorus of ATP. Site-directed mutagenesis studies and comparison
of these structures with that of homologous N-acetyl-L-glutamate and isopentenyl phosphate
kinases allowed us to propose a model of phosphorylation of fosfomycin by FomA enzyme. A Mg
cation ligates all three phosphate groups of ATP and together with positively charged K216, K9,
K18, and H58 participates in the dissipation of negative charge during phosphoryl transfer,
indicating that the transferred phosphate group is highly negatively charged, which would be
expected for an associative mechanism. K216 polarizes the γ-phosphoryl group of ATP. K9, K18,
and H58 participate in stabilization of the transition state. D150 and D208 play organizational
roles in catalysis. S148, S149, and T210 participate in fosfomycin binding, with T210 being
crucial for catalysis. Hence, it appears that as in the homologous enzymes, FomA-catalyzed
phosphoryl transfer takes place by an in-line predominantly associative mechanism.
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Antibiotic resistance is a continuously emerging problem that poses a significant threat to
global public health. Many previously known “miracle” drugs have lost their effectiveness
against bacteria. On the other hand, very few new antimicrobial agents are brought to the
market. Rather than searching for new antimicrobial agents, researchers in the field of drug
discovery have emphasized the development of new improved formulations, more effective
delivery systems, and understanding of resistance mechanisms. A comprehensive
understanding of the resistance mechanism is a key requirement in the drug discovery
process. Such knowledge can be exploited in designing inhibitors that can be effective
against antibiotic resistance.
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Fosfomycin (cis-1,2-epoxypropylphosphonic acid) (Scheme 1) is a common broad-spectrum
antibiotic successfully used to treat urinary tract infections. Its mode of action is based on
the inhibition of the enzyme UDP-N-acetylglucosamine-3-O-enolpyruvyl transferase, which
is responsible for the first stage of peptidoglycan biosynthesis.1 Fosfomycin is considered to
be a somewhat “old” drug because it has been prescribed in clinical practice since 1969.2,3
Nevertheless, it is still the only drug approved by the Food and Drug Administration for
treatment of acute cystitis during pregnancy.4 Successful application of the antibiotic for
treatment of multidrug-resistant Gram-positive and Gram-negative bacterial infections in
combination with other antibiotics has recently been reported,5 which prompted further
evaluation of its potential clinical effectiveness, especially in cases involving multidrugresistant pathogens in which previous antibiotics have failed to cure the infection.
One of the most attractive features of fosfomycin is the chemical stability of the molecule.
The combination of a carbon–phosphorus bond in conjunction with the epoxide ring makes
the molecule extremely stable. It has almost no toxicity in humans,2 is eliminated in the
kidneys in its active form without metabolites, and can be dialyzed. However, several
fosfomycin resistance proteins, namely, FosA, FosB, FosC, and FosX, that inactivate the
antibiotic by different mechanisms are described in the literature.6–9 Fosfomycin resistance
kinases FomA and FomB are the newest representatives of the class of fosfomycin
resistance proteins.10,11 Together, these novel enzymes inactivate fosfomycin by
phosphorylation of the antibiotic’s phosphonate group (Scheme 1).
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We previously described the high-resolution crystal structure of fosfomycin resistance
protein FomA from Streptomyces wedmorensis in a complex with diphosphate (DPO) and in
a ternary complex with MgAMPPNP and fosfomycin (MgAMPPNP·fosfomycin) at 1.53 and
2.2 Å resolution, respectively.12 The structures revealed the molecular fold of the protein,
which classifies it among the members of the amino acid kinase (AAK) superfamily of
enzymes, identified the active site residues of FomA that could be responsible for substrate
binding and specificity, and elucidated their proposed roles in catalysis. A high degree of
similarity in molecular fold as well as in the organization of the active sites was observed
between FomA and the N-acetyl-L-glutamate kinase (NAGK), for which the catalytic
reaction is well studied and proceeds via the associative in-line mechanism.13 However, the
ternary complexes of the two enzymes, which superimpose well with respect to substrates
and catalytic residues K9, K216, and D150 (FomA numbering), show different orientations
of the γ-phosphates of the nucleotide molecules. In addition, the triphosphate tail of
AMPPNP is not aligned toward the phosphonate group of fosfomycin, and the shortest
distance between oxygen atoms of the phosphonate group of fosfomycin and the phosphorus
atom of AMPPNP is 5.19 Å, a value that is too long for the optimal in-line phosphoryl
transfer reaction. Such observations suggested that the FomA-catalyzed reaction may
proceed by a mechanism different from that observed for NAGK, or the catalytic
conformation of ATP may be significantly different from the one observed for AMPPNP in
the MgAMPPNP·fosfomycin crystal structure. To address these questions, we determined
crystal structures of additional ternary complexes of FomA that provide an approximation of
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different reaction steps: with MgATP (MgATP), with ATP and fosfomycin
(ATP·fosfomycin), with MgADP and fosfomycin vanadate (MgADP·FMVO3), with
MgADP and the product of the enzymatic reaction, fosfomycin monophosphate
(MgADP·FM), and with ADP (ADP). Site-directed mutagenesis studies presented here
helped to determine the role of different active site residues in catalysis.

EXPERIMENTAL PROCEDURES
Chemicals and Materials
Fosfomycin monophosphate was enzymatically synthesized, purified, and kindly provided
by T. Kuzuyama (The University of Tokyo, Tokyo, Japan). All other chemicals were
purchased from Sigma/Fluka at the highest grade available.
Protein Preparation and Crystallization
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Protein was expressed and purified according to the published procedure.12 Studied
complexes have been obtained by soaking FomA crystals grown as described previously12
in modified mother liquor for at least 30 min prior to the collection of data. The
compositions of soaking solutions were as follows: 17% PEG 3350, 15% glycerol, 0.1 M
MES (pH 5.5), 10 mM ATP, and 10 mM MgCl2 (MgATP complex); 17% PEG 3350, 25%
glycerol, 0.1 M MES (pH 7.1), 10 mM ATP, and 10 mM fosfomycin (ATP·fosfomycin
complex); 17% PEG 3350, 25% glycerol, 0.1 M MES (pH 7.0), 10 mM ADP, 50 mM
MgCl2, 10 mM fosfomycin, and 10 mM NaVO3 (MgADP·FMVO3 complex); 17% PEG
3350, 25% glycerol, 0.1 M MES (pH 7.0), 10 mM ADP, 50 mM MgCl2, and 10 mM
fosfomycin monophosphate (MgADP·FM complex); and 17% PEG 3350, 25% glycerol, 0.1
M MES (pH 7.0), 10 mM ADP, and 50 mM MgCl2 (ADP complex).
Data Collection
Diffraction data were collected at 100 K at the PX station at the Center for Advanced
Microstructures and Devices at Louisiana State University with a MAR charge-coupled
device camera. Data were processed with HKL2000.14 Data collection and data processing
statistics are listed in Table 1.
Determination of Crystal Structures

NIH-PA Author Manuscript

The molecular replacement procedure (MR) was applied to locate a solution. A monomer of
FomA from the FomA·MgAMPPNP·fosfomycin ternary complex (Protein Data Bank entry
3D41) was used as a search model. The positioned MR models were refined using the
maximum likelihood refinement in REFMAC15 with the TLS parameters generated by the
TLSMD server.16 TLS tensors were analyzed, and anisotropic B factors were derived with
TLSANL.17 O18 was used for model building throughout the refinement. Details of
refinement of each particular complex follow.
MgATP Complex
The presence of ATP and Mg2+ cation was confirmed by difference Fourier. One glycerol
molecule was modeled in the active site according to the electron density shape. Nine
residues (residues −8 to 0) of the N-terminal poly-His tag were visible and were modeled
into the electron density. The final model consists of protein residues −8 to 56, 70–178,
182–202, and 211–262. Alternate conformations have been built for residues M1, L6, L115,
R116, S117, and Q118. A total 108 water molecules have been added to the final model.
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The final model consists of protein residues −11 to 177, 183–205, and 212–264, one ATP,
one fosfomycin, and 203 water molecules. Alternate conformations have been built for
protein residues L6, I8, Y43, V82, and C106.
MgADP·FMVO3 Complex
The final model consists of protein residues −11 to 262, one ADP molecule, one Mg2+
cation, one fosfomycin vanadate, and 136 water molecules. Alternate conformations have
been built for protein residues L6, I8, Y43, C106, and E161.
MgADP·FM Complex
The final model consists of protein residues −8 to 55, 69–178, 183–205, and 211–262, one
ADP molecule, one Mg2+ cation, one fosfomycin monophosphate, and 232 water molecules.
Alternate conformations have been built for protein residues L6, I8, Y43, C106, L115, S193,
and R226.
ADP Complex
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The final model consists of protein residues −8 to 62, 68–204, and 211–262, one ADP
molecule, and 169 water molecules. Despite the fact that the soaking solution contained a
high concentration of MgCl2, no electron density that could be attributed to Mg2+ cations
was observed in the active site. Alternate conformations have been built for amino acid
residues L6, I8, Y43, and C106.
Generation of S148A, S149A, T210A, H58L, K9A, K18A, and D208A Mutants
Mutants were created using whole plasmid PCR and Pfu UltraII polymerase (Stratagene) as
described previously.19 All mutant enzymes were expressed in bacteria as soluble proteins
in yields comparable to that of the wild-type enzyme. They were isolated and purified
essentially as described for the native protein.
Kinetic Studies
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Kinetic measurements for wild-type FomA and all site-specific FomA mutants were
performed at 25 °C using the pyruvate kinase–lactate dehydrogenase coupled assay.10 The
reaction mixture in a volume of 1 mL contained 4.6 units of pyruvate kinase, 6.6 units of
lactate dehydrogenase, 100 mM sodium HEPES buffer (pH 7.2), 10 mM MgCl2, 0.3 mM
NADH, 1 mM phosphoenolpyruvate (PEP), 100 mM KCl, and several concentrations of
fosfomycin and ATP. The reaction rate was measured for 15 min. The Km for fosfomycin
was determined using an enzyme assay system containing 1 mM Na2ATP2− and various
concentrations of fosfomycin. The reaction was initiated by the addition of purified FomA
(18 µg) or FomA mutants (107 and 193 µg for S148A and S149A mutants, respectively).
Reaction volumes of 170 µL and 287 µg of K9A or 630 µg of D208A in an assay were used
to measure kinetic data in the case of the K9A and D208A mutants. Data were analyzed with
curve fitting in Sigmaplot. The Km for Na2ATP2− was determined using an enzyme assay
system containing 1 mM fosfomycin and various Na2ATP2− concentrations. The reaction
was initiated by the addition of the same amount of purified FomA or FomA mutants as in
the case of the determination of the Km for fosfomycin. Data were analyzed as stated above
for fosfomycin.
Figures
All figures of structures were made using PYMOL.20
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RESULTS
Overall Fold
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Five crystalline FomA complexes presented here and two previously reported12
MgAMPPNP·fosfomycin and DPO structures are isomorphous and exhibit the same overall
open αβα sandwich polypeptide fold (Figure 1). The root-mean-square deviations (rmsd) for
the equivalent CA atoms between all the structures are less than 1 Å. The enzyme molecules
in different complexes show conformational flexibility in four different parts, all of which
surround the active site (Figure 1 and Table 1 of the Supporting Information). The loop
consisting of residues 16–24 is highly flexible and adopts different conformations in the
structures. This loop contains K18, an amino acid residue that was proposed to be important
for the catalysis because it forms a hydrogen bond between the NZ atom and a nonbridging
oxygen atom of the γ-phosphoryl group of ATP in the MgAMPPNP·fosfomycin complex.
Similar H-bonding is also observed in the ATP·fosfomycin complex. The rest of the FomA
complexes lack this H-bond. In the MgATP complex, the loop adopts a notably different
conformation, turning away from the active site such that K18 (CA) moves up
approximately 5 Å in comparison to all the other complexes and is no longer part of the
active site.
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Residues 52–69 are mostly disordered in the DPO, MgATP, and MgADP·FM complexes (no
electron density observed), while they are ordered in the MgAMPPNP·fosfomycin,
MgADP·FMVO3, and ATP·fosfomycin structures where they participate in the formation of
helix α2 (residues 53–64). The binding of fosfomycin or fosfomycin vanadate appears to be
necessary for the ordering of this part of the protein molecule. However, this portion of the
molecule is disordered in the MgADP·FM structure despite the fact that the fosfomycin
binding site is occupied by the product of the reaction, fosfomycin monophosphate. Such
disorder could be explained by the fact that residues 52–69 could also participate in product
release.
The loop of residues 177–183, which is basically covering the adenine ring of ATP, is
usually very disordered. It has defined electron density only in the MgADP·FMVO3 and
ADP complexes.
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The segment of amino acid residues 201–212 extends through the entire active site (Figure
1) and is usually not visible in electron density maps. The MgAMPPNP·fosfomycin and
MgADP·FMVO3 structures are the only complexes in which this part of the enzyme
molecule is ordered. However, amino acid residues 203–211 adopt somewhat different
positions. The ordering of the segment of residues 201–212 is in agreement with the
ordering of the segment of residues 52–69 of the protein molecule provided that Mg2+ is
bound. The corresponding part is also disordered in all known crystal structures of
isopentenyl phosphate kinases (IPKs). Residues 201–208 essentially cover the nucleotide
binding site. There is a notable difference in the conformation of residue W202 between
different complexes. W202 is a part of helix α6 (amino acids 195–203) in the DPO,
ATP·fosfomycin, MgADP·FM, and ADP complexes and points away from the active site.
However, helix α6 becomes broken at amino acid 200 in the MgADP·FMVO3,
MgAMPPNP·fosfomycin, and MgATP crystal structures so that W202 moves closer to the
nucleotide binding site and participates in stacking interactions with the adenine ring of a
nucleotide (Figure 2A,C), hence closing the nucleotide binding site and preparing the
enzyme for the reaction. The remainder of the amino acid residues (residues 209–212) are in
the proximity of the fosfomycin binding site. The hydroxyl group of T210 directly
participates in fosfomycin binding via a hydrogen bond to O3 of the phosphonate moiety of
fosfomycin as it is seen in the MgAMPPNP·fosfomycin and MgADP·FMVO3 complexes
(Figure 2C). As discussed later, T210 is also crucial for catalysis.
Biochemistry. Author manuscript; available in PMC 2012 August 16.
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MgATP Complex
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The biggest difference between the MgATP and MgAMPPNP·fosfomycin complexes is
observed in the orientation of the γ-phosphoryl group of the nucleotides. In the MgATP
structure, it is positioned closer to the fosfomycin binding site (Figure 2A). This
conformation is fixed by two hydrogen bonds between nonbridging oxygen atoms of the γphosphoryl group of ATP and the side chain nitrogen of K9 and the main chain nitrogen of
G12, which are not observed in the latter structure. There is also a 2.74 Å hydrogen bond
between O1G of the γ-phosphoryl group of ATP and the hydroxyl group of glycerol (3.7 Å
to Pγ). The oxygen from the hydroxyl group of glycerol mimics the position of the attacking
oxygen of the phosphonate group of fosfomycin. The Oβγ−Pγ−Oglycerol angle is 154.8°. The
Mg2+ cation is five-coordinated and is chelated by the nonbridging oxygen atoms of the α-,
β-, and γ-phosphate groups of ATP (2.18, 2.82, and 2.18 Å, respectively), a hydroxyl group
of glycerol (2.92 Å), and one water molecule (3.12 Å). Extensive disorder of the protein
molecule is observed around the fosfomycin binding site, which results in wide-open access
to the binding site. The adenine moiety of ATP makes stacking interactions with the side
chain of W202 as it does in the MgAMPPNP·fosfomycin complex.
ATP·Fosfomycin Complex
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Despite the fact that this crystal structure does not contain Mg2+, the ATP conformation and
the system of hydrogen bonds are basically the same as those observed for the AMPPNP
molecule in the MgAMPPNP·fosfomycin complex (Figure 2B). The only differences
between the two structures are that W202 in the former complex no longer makes stacking
interactions with the adenine ring of the nucleotide and that the segment of amino acid
residues 206–211, which is adjacent to the magnesium binding site, is disordered with no
clear electron density. There is an active site water molecule that mimics the position of one
oxygen atom of the γ-phosphate group of ATP in the MgATP complex.
MgADP·FMVO3 Complex
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This complex represents the least disordered and the most complete FomA structure. It is the
only structure of the five structures reported here with an ordered K9, K18, K216 lysine
triangle. The lysine triangle is also ordered in the MgAMPPNP·fosfomycin crystal structure
reported previously.12 However, as will be discussed later, the nucleotide conformation in
that structure does not represent the active one and thus is not mechanistically significant.
The bond lengths observed indicate that vanadate is covalently bound to the attacking
oxygen atom of the phosphonate group of fosfomycin. Hence, fosfomycin vanadate mimics
the product of the reaction, fosfomycin monophosphate, and not the transition intermediate.
D150 not only coordinates catalytic residues K216 and K9 through salt bridges but also
makes H-bonds to two water molecules from the Mg coordination sphere. Magnesium is in
the ideal six-coordination state and is chelated by nonbridging oxygen atoms of the α- and βphosphate groups of ATP (2.15 and 2.12 Å, respectively), one oxygen atom of fosfomycin
vanadate (2.36 Å), and three water molecules (1.96, 2.02, and 2.08 Å). The adenine ring of
ADP is covered by the side chain of W202 by means of stacking interactions. The side chain
nitrogen of K18 forms H-bonds with one oxygen of vanadate of fosfomycin vanadate and
one nonbridging oxygen of the β-phosphoryl group of ADP (Figure 2C). The side chain
nitrogen of K9 is coordinated with another oxygen of the vanadate moiety. The same
vanadate oxygen is also H-bonded with Nε2 of H58. Thus, K9, K18, and H58 are the only
residues directly involved in interactions with the vanadate moiety of fosfomycin vanadate,
and most likely, these positively charged amino acid residues directly participate in the
stabilization of the transition state.
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MgADP·FM Complex
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The structure is significantly disordered in the active site region. There is no electron density
for residues 56–68, 179–182, and 207–210, all of which cover the active site in the
MgADP·FMVO3 complex. Amino acid residue K18 does not have defined electron density
for the side chain. There is a water molecule in the place of NZ of K18 in the MgADP·VO3
complex. The glycine rich loop of residues 53–57 is positioned differently compared to that
observed in the MgADP·FMVO3 structure, placing residue G54 away from the active site as
in the DPO complex. No stacking interactions between the side chain of W202 and the
adenine ring of ADP are observed. Mg2+ is only four-coordinated [2.19 Å from one oxygen
of the phosphate group of fosfomycin monophosphate, 2.17 and 2.67 Å from nonbridging
oxygen atoms of the α- and β-phosphate groups of ADP, respectively, and 2.07 Å from a
water molecule (Figure 2D)].
ADP Complex
This structure is very similar to that of the MgADP·FM complex. The active side is wideopen because of the extensive disorder of protein loops surrounding it. There are no stacking
interactions between the side chain of W202 and the adenine ring of ADP (Figure 2E). The
space occupied by the NZ atom of K18 in the MgADP·FMVO3 complex is occupied by a
water molecule as in the MgADP·FM complex.
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Characterization of FomA Mutants
The previously reported MgAMPPNP·fosfomycin structure12 identified K18, H58, and
D208 as possible catalytic residues in addition to the counterparts of NAGK’s catalytic
residues K9, K216, and D150. S148, S149, and T210 are residues that participate in
fosfomycin binding. We have performed site-directed mutagenesis studies to improve our
understanding of the roles of these amino acids in the phosphorylation of fosfomycin by
FomA. S148A, S149A, T210A, H58L, K18A, K9A, and D208A FomA mutants were
expressed and kinetically characterized (Table 2).
Nucleotide Binding Site
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K9, K216, and D150 correspond to K8, K217, and D162, respectively, in NAGK. In NAGK,
K8 and K217 are centrally involved in phosphoryl transfer. K8 stabilizes the transition state
by abstracting a developing negative charge, while K217 polarizes the γ-phosphoryl group
of ATP. D162 makes salt bridges with both K8 and K217. A D162E mutation shows a 1000fold decrease in Vm,21 consistent with the suggestion that D162 organizes catalytic residues
K8 and K217. A similar structural feature is found in the FomA protein (K9, K216, and
D150 amino acids). Although we did not test the influence of K216 and D150 mutations on
the kinetic parameters of the FomA reaction, the strong structural correlation with NAGK
and other members of the AAK superfamily of enzymes suggests that D150 plays a similar
organizing role in the FomA-catalyzed reaction while K216 likely participates in
polarization of the γ-phosphoryl group of ATP. D150 and D208 also belong to the outer
coordination sphere of the Mg cation, making strong hydrogen bonds to magnesiumcoordinated water molecules in the MgADP·FMVO3 [H-bonds to two water molecules and
one water molecule for D150 and D208, respectively (Figure 2C)], MgAMPPNP·fosfomycin
(one H-bond each for D150 and D208), and MgADP·FM (H-bond to one water molecule
only for D150) complexes. Such an observation could suggest that D150 and D208 also
participate in stabilization of the Mg coordination sphere, which in turn organizes the
phosphate chain of ATP for phosphoryl transfer. Indeed, the D208A mutation showed a
substantial (~15-fold) decrease in kcat (Table 2), suggesting that D208 could participate in
such stabilization. Sequence alignment of FomA with IPKs showed that all the IPKs have
conserved this aspartate residue. However, all known crystal structures of IPKs have that
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part of the protein molecule disordered and do not allow structural analysis of this particular
aspartate residue.
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According to the crystal structures of FomA complexes, K9 accompanies the γ-phosphoryl
group of ATP during the phosphoryl transfer. Its NZ group is H-bonded to the γ-phosphate
of ATP in the MgATP complex (Figure 2A), one oxygen atom of the vanadate moiety in the
MgADP·FMVO3 complex (Figure 2C), and one oxygen of the phosphate group of
fosfomycin monophosphate in the MgADP·FM complex (Figure 2D). The corresponding
residue in NAGK (K8) was proposed to participate in the stabilization of the transition state.
The K9A mutation in FomA showed an ~40-fold decrease in the kcat value, indicating that
this residue is indeed important for catalysis.
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Structural data for the MgAMPPNP·fosfomycin complex12 suggested the possible
involvement of the positive charge of the side chain of K18 in the catalysis of phosphoryl
group transfer. The NZ group of K18 is hydrogen bonded to the nonbridging oxygen atom
of the γ-phosphoryl group of ATP in the ATP·fosfomycin (Figure 2B) and
MgAMPPNP·fosfomycin complexes. However, as we will discuss below, the nucleotide
conformations in these two complexes do not represent the active one. Hence, such an
interaction is most likely irrelevant for catalysis. In the MgADP·FMVO3 structure, however,
the NZ group of K18 is hydrogen bonded to both a nonbridging oxygen atom of the βphosphoryl group of ADP and an oxygen atom of the vanadate moiety of fosfomycin
vanadate (Figure 2C). Moreover, this residue is not visible at all in the MgATP,
MgADP·FM, and ADP complexes. A K18A mutation resulted in an inactivated enzyme.
Hence, structural and kinetic data suggest that K18 most likely participates in transition state
stabilization.
In the MgAMPPNP·fosfomycin structure, H58 was found virtually at the midpoint of the
phosphoryl transfer site in the proximity of both the fosfomycin (3.83 Å) and AMPPNP
molecule (3.45 Å), suggesting that H58 could contribute to catalysis. Moreover, this residue
is also conserved in all IPKs. Kinetic studies using different mutants in MJ IPK have shown
that this histidine residue plays an essential role in catalysis through hydrogen bond
stabilization of the transition state accompanying the nucleophilic displacement of ADP.22
H60A and H60N mutants completely lose their enzymatic activity, while the H60Q mutant
still shows measurable activity. In all known crystal structures of IPKs, this histidine residue
makes a hydrogen bond with the terminal phosphates of the substrate isopentenyl
monophosphate or the product isopentenyl diphosphate.
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H58 is visible only in the MgAMPPNP·fosfomycin, ATP·fosfomycin, and MgADP·FMVO3
FomA complexes (first two complexes have catalytically irrelevant nucleotide
conformations, though). In the MgADP·FMVO3 structure, H58 is hydrogen bonded to one
oxygen atom of the vanadate moiety of fosfomycin vanadate (Figure 2C). An H58L
mutation abolished the catalytic activity of FomA, confirming that this residue is crucial for
catalysis. On the basis of kinetic and structural data, we conclude that H58 participates in the
stabilization of the transition state of the FomA-catalyzed reaction as in the case of H60 in
IPKs.
Fosfomycin Binding Site
The MgAMPPNP·fosfomycin complex showed that three amino acid residues (S148, S149,
and T210) hold the substrate fosfomycin in place by hydrogen bonds to the nonattacking
phosphonate oxygens of fosfomycin. 12 The increases in Kmfos values associated with the
S148A and S149A mutations (~17- and 38-fold increases, respectively) strongly suggest that
these mutations hamper fosfomycin binding. All known IPKs have an invariant serine
residue at the same position as S148 in FomA. The replacement of T210 with alanine caused
Biochemistry. Author manuscript; available in PMC 2012 August 16.
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essentially a total loss of enzymatic activity (Table 2), indicating that T210 is crucial for the
catalysis. T210 is visible only in the MgAMPPNP·fosfomycin and MgADP·FMVO3
complexes, suggesting that this residue most likely participates in transition state
stabilization. T210 also belongs to the outer magnesium coordination sphere and makes a
strong hydrogen bond (according to the bond length and geometry) to one water molecule.
Hence, it could play an organizing role in catalysis, as well.
Although enzymes of the carboxylate division of the AAK superfamily do not have residues
that could align with the segment of residues 203–211 of FomA, the recent crystal structure
of carbamate kinase (CK) from Enterococcus faecalis23 showed that the side chain of K128
superimposes very well onto T210 of FomA. K128 belongs to the flexible protruding
subdomain that hangs over the active site and is an exclusive feature of CKs. A K128A
mutation resulted in a very large decrease in kcat and an increase in KmCP (~2000- and ~600fold, respectively, relative to those of the wild-type enzyme in identical assays). On the basis
of their data, the authors suggested that K128 in CKs most likely participates in substrate–
product binding and transition state stabilization, the same role that has been proposed for
T210 in FomA. However, in contrast to T210 in FomA, the positively charged side chain of
K128 could also participate in withdrawal of the negative charge from carbamoyl phosphate
and/or in a neutralization of the negative charge on the γ-phosphate of ATP.
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Our comparative analysis is based on crystal structures of seven FomA complexes that
approximate different reaction steps of the FomA-catalyzed enzymatic reaction. The DPO
complex could be considered as a ground state when none of the required substrates is
bound in the active site of the enzyme. The MgATP and ATP·fosfomycin complexes may
represent the early stages of the reaction in which only two of three necessary reaction
components (ATP, fosfomycin, and Mg2+ cation) are present. The MgAMPPNP·fosfomycin
complex may approximate the next reaction stage at which all the substrates are bound and
the reaction is ready to proceed. However, AMPPNP is an inert ATP analogue. Hence, the
catalytic conformation of ATP is not necessarily the one observed in the
MgAMPPNP·fosfomycin complex. A pentacoordinate transition state complex is considered
to be the approximation of the midway reaction stage for the SN2-type nucleophilic
reactions. It has been shown24–26 that aluminum fluoride, vanadate, or nitrate ions can
successfully be used to mimic the γ-phosphoryl group in the catalytic transition state. Our
efforts to obtain transition state analogue complexes with either the aluminum fluoride or
nitrate ion proved fruitless. Neither AlF3 nor NO3− binds in the active site of the enzyme.
Inclusion of NaVO3 in the soaking solution resulted in the crystal complex in which
vanadate covalently binds to the fosfomycin, forming fosfomycin vanadate. Such a complex
with four-coordinate vanadate mimics the product of the reaction rather than the transition
state analogue. The MgADP·FM and ADP complexes represent the final reaction steps. (1)
The MgADP·FM complex shows the enzymatic reaction is complete. (2) The ADP complex
shows the reaction is complete and the product is released.
Fosfomycin Resistance Kinase versus Isopentenyl Phosphate Kinases
Members of the AAK superfamily of enzymes phosphorylate carboxylate, carbamate,
phosphonate, or phosphate functional groups using ATP and Mg2+. The superfamily is
divided into two subdivisions according to the nature of the phosphorylated group: the
carboxylate subdivision and the phosphate subdivision. The known members of the
carboxylate subdivision are carbamate kinase (CK),27 the N-terminal domain of
aspartokinase (AK),28 glutamate 5-kinase (GK),29 and N-acetyl-L-glutamate kinase
(NAGK).13 The phosphate subdivision consists of uridine monophosphate kinase
(UMPK),30 fosfomycin resistance kinase FomA, and recently discovered isopentenyl
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phosphate kinase (IPK).22,31 At the time of initial structural characterization of FomA
kinase, NAGK appeared to be the most structurally related homologue. Our predictions of
the mechanism of the reaction catalyzed by FomA were made on the basis of a structural
comparison with NAGK, which proceeds via a predominantly associative mechanism. The
crystal structure of FomA showed preservation of catalytic amino acids of NAGK (K9,
K216, and D150 in FomA) as well as good superposition of the phosphate acceptor groups
of the substrates. Recently, crystallographic data for IPKs from different organisms have
become available: from Methanocaldococcus jannaschii (MJ),22 from Thermoplasma
aciduphilum (THA),31 and from Methanothermobacter thermautotropicus (MTH).31 IPKs
phosphorylate isopentenyl monophosphate, producing isopentenyl diphosphate, a reaction
analogous to that catalyzed by FomA. IPKs exhibit the most structural similarities with
FomA, despite a low level of sequence identity to FomA (22–25%), expanding the
possibilities for structural comparisons and mechanistic investigations. Structural alignment
of FomA with IPKs shows conservation of all previously identified catalytic residues of
FomA (K9, K216, and D150) as well as amino acid residues H58 and K18, which have been
previously identified in FomA as residues that could be essential for catalysis. H58 and K18
are invariant in all known FomA and IPK enzymes. Members of the carboxylate subdivision
of the AAK superfamily of enzymes lack such equivalent residues in their sequences. In
addition, the substrate binding sites (fosfomycin or isopentenyl monophosphate) in all
known FomAs and IPKs have invariant S148, D208, T210, and G211 amino acids (FomA
amino acid numbering). Such observations strongly support the suggestion that FomA- and
IPK-catalyzed reactions proceed via a similar mechanism. In contrast, bacterial UMP
kinases, which belong to the last group of the phosphate subdivision of the AAK
superfamily of enzymes, share significantly less sequence homology with FomA (19% at the
most), nor do they show conservation of the FomA catalytically important amino acids K9
(D, S, or K in UMPKs), K216 (A in UMPKs), and H58 (R in UMPKs); there is no residue
equivalent to K18. In terms of quaternary structure, they form stable homohexameric
architectures with allosteric regulation, while FomA and IPK enzymes adopt homodimers
with no documented allosteric regulation. Hence, the mechanism of phosphorylation by
UMPK is likely distinct from that of FomA or IPK enzymes.
ATP Conformation
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The ATP conformation is different between two complexes containing the ATP molecule:
the ATP·fosfomycin form and the MgATP one. While the ATP conformation in the former
structure is basically the same as that observed in the MgAMPPNP·fosfomycin complex, the
γ-phosphate of ATP in the latter structure adopts a different orientation, placing the leaving
phosphate group closer to the fosfomycin binding site (Figure 3A). The catalytically relevant
conformation of ATP is most likely the one observed in the MgATP structure because (1)
the MgATP structure contains the catalytic Mg2+ cation that binds to ATP and properly
orients it for phosphoryl transfer, (2) the γ-phosphoryl group of the ATP molecule is closer
to the fosfomycin binding site and is positioned for in-line transfer, (3) there is better
superposition between the nucleotides between the MgATP and the structurally homologous
N-acetyl-L-glutamate and isopentenyl phosphate kinases, and (4) one of the nonbridging O
atoms of the γ-phosphoryl group of ATP in the MgATP structure shares almost the same site
as one of the O atoms of the phosphate group of the product of the reaction, fosfomycin
monophosphate, in the MgADP·FM structure (Figure 3B) or one of the O atoms of the
vanadate moiety in the MgADP·FMVO3 structure.
We built the model of the MgATP·fosfomycin ternary complex using the coordinates of
FomA, ATP, and Mg2+ from the MgATP complex and the superimposed fosfomycin
coordinates from the ATP·fosfomycin structure (Figure 3A). According to the model, the
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distance between the attacking O atom of fosfomycin and the P atom of the γ-phosphate of
ATP is 4.0 Å and the Oβγ−Pγ−Ofos angle is 157.9°.
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The MgADP·FMVO3 Complex Mimics the Charge Distribution of the Transition State
Two possible reaction mechanisms are generally described for phosphoryl transfer: an
associative mechanism (SN2-like) or a dissociative mechanism (SN1-like). The two
mechanisms differ in the charge distribution and bond order of the transition state. The SN2
mechanism is characterized by the formation of the pentacoordinate bipyramidal transition
state in which the axial ligands are the nucleophile of the attacking substrate and the
bridging oxygen atom between the β- and γ-phosphates. An overall charge distribution for
such a transition state is −3. A planar trigonal metaphosphate with an overall charge of −1 is
observed for the dissociative mechanism. Hence, the location of positively charged amino
acids and the distances from the phosphoryl analogue to the leaving and attacking groups are
crucial to distinguish between two possible mechanisms.
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Despite our numerous efforts to obtain a pentacoordinate transition state FomA complex, we
were able to obtain only a complex in which vanadate is covalently bound to fosfomycin.
Formation of such a compound is not unprecedented because monomeric vanadate is known
to react readily with phosphate or alkyl phosphate to form phosphovanadate or alkyl
phosphovanadate.32 Fosfomycin vanadate mimics the product of the reaction, fosfomycin
monophosphate, rather than the transition state. All the ligands superimpose very well
between the MgADP·FMVO3 and MgADP·FM complexes. However, a detailed comparison
of two complexes surprisingly reveals many significant differences in terms of protein
conformation (Figure 4). The MgADP·FMVO3 complex is the most ordered one among all
the FomA crystal structures and the only one that has the ordered so-called “lysine triangle”
(K9, K18, and K216). A lysine triangle has been shown to play a catalytic role in
isopentenyl phosphate kinases. The MgADP·FM structure has extensive disorder of the
loops surrounding the active site, which may indicate that the enzymatic reaction is
complete, and the active site loops moved out to allow the product of the reaction,
fosfomycin monophosphate, to leave the enzyme active site (Figure 4A,B). In contrast, the
active site of the enzyme in the MgADP·FMVO3 complex is closed (Figure 4B). All the
loops surrounding the active site are ordered, and the side chain of W202 makes stacking
interactions with the adenine ring of ADP. All the amino acids (K9, K18, H58, D208, and
T210) that were proposed to play role in the catalytic reaction are ordered in contrast to the
MgADP·FM structure in which they are mostly disordered with no electron density at all
(H58, D208, and T210) or with missing electron density for the side chain (K18). There are
also differences in the Mg coordination. The MgADP·FMVO3 complex has the Mg cation in
a perfect octahedral coordination, while it is only tetracoordinated in the MgADP·FM
structure. Such observations and structural differences with the MgATP complex (one of the
initial stages of the reaction) in terms of the conformation of the FomA molecule suggest
that the conformation of the protein molecule in the MgADP·FMVO3 complex depicts the
one between these two stages (before and after catalysis). The ordering of the structure and
the locations of several positively charged amino acid residues in the active site close to the
vanadate moiety of fosfomycin vanadate suggest that the MgADP·FMVO3 complex
approximates the charge distribution in the transition state.
Proposed Enzymatic Mechanism
Taking into account the results of our mutational and structural studies, as well as the
sequence conservation in homologous enzymes, we proposed a mechanism of fosfomycin
inactivation by FomA protein (Figure 5).
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The attacking O atom of fosfomycin is clearly identified. In the model of the
MgATP·fosfomycin complex, the angle among this atom, Pγ of ATP, and the bridging Oβγ is
157.9°, which is close for the expected in-line attack on phosphorus with formation of a
trigonal bipyramidal transition state. The distance between the attacking O atom of the
fosfomycin and the P atom of the γ-phosphate of ATP is 4.0 Å, which is 0.9 Å too short for
a dissociative mechanism,33 suggesting a mechanism with some associative character.
Negative charges on ATP are shielded by Mg2+, which ligates all three phosphate groups, by
K216, which is H-bonded to the β-phosphate of ATP or ADP in all FomA complexes, and
by several positively charged amino acid residues (K9, K18, and H58), which are precisely
located around the vanadate moiety of fosfomycin vanadate in the MgADP·FMVO3
complex. Glycine rich loops 11GGSLFS16 and 53GGG55 may provide additional charge
stabilization and function as flexible clamps stabilizing the leaving phosphate and entering
phosphonate groups. A high density of positive charges in the phosphoryl transfer site
indicates that the transferred phosphate group is highly negatively charged, as would be
expected for an associative mechanism. Substrate binding is followed by closure of the
active site loops, resulting in ordering and movement of catalytic residues K18, H58, and
T210 closer to the midpoint of the phosphoryl transfer site as it is observed in the
MgADP·FMVO3 complex, thus participating in transition state stabilization. After
phosphoryl transfer is complete, the loops move away to help to release the product of the
reaction, fosfomycin monophosphate. Hence, it appears that as in the homologous enzymes
that also have similarly organized active centers and ternary complexes, FomA-catalyzed
phosphoryl transfer takes place by an in-line predominantly associative mechanism.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ABBREVIATIONS
AAK

amino acid kinase

NAGK

N-acetyl-L-glutamate kinase

AK

N-terminal domain of aspartokinase

CK

carbamate kinase

GK

glutamate 5-kinase

UMPK

uridine monophosphate kinase

IPK

isopentenyl phosphate kinase

NAG

N-acetyl-L-glutamate

FM

fosfomycin monophosphate
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FMVO3

fosfomycin vanadate

DPO

diphosphate

MJ IPK

M. jannaschii isopentenyl phosphate kinase

THA IPK

T. aciduphilum isopentenyl phosphate kinase

MTH IPK

Me. thermautotropicus isopentenyl phosphate kinase
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Figure 1.

Cartoon representation of a monomer of FomA as it is seen in the MgADP·FMVO3
complex. Ligand molecules are shown as sticks, and Mg2+ is shown as a green sphere.
Flexible parts of the protein molecule are colored red.
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Figure 2.

Stereoviews of the active sites in (A) MgATP, (B) ATP·fosfomycin, (C) MgADP·FMVO3,
(D) MgADP·FM, and (E) ADP complexes. The ligand molecules are shown as sticks, Mg2+
atoms as spheres, and water molecules as crosses, and the interacting protein residues are
colored blue.
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Figure 3.

(A) Model of the MgATP·fosfomycin complex based on a superposition of MgATP from
the MgATP complex and fosfomycin from the ATP·fosfomycin complex. The attacking
oxygen of fosfomycin is 4.0 Å from the γ-phosphorus of ATP. Mg2+ is shown as a green
sphere. The superimposed ATP molecule from the ATP·fosfomycin complex is colored
wheat. (B) Same as panel A with a superposition of fosfomycin monophosphate (yellow).
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(A) Superposition of the active sites of the MgADP·FM (green) and MgADP·FMVO3
(purple) complexes. Ligand molecules are shown as sticks and Mg2+ cations as spheres;
ADP and fosfomycin vanadate molecules from the MgADP·FMVO3 complex are colored
teal. (B) Surface representation for the MgADP·FM (left) and MgADP·FMVO3 (right)
complexes. Ligand molecules (shown as sticks) are exposed to solvent in the former
complex, while they are shielded by flexible protein loops in the latter.
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Figure 5.

Phosphoryl group transfer in the FomA reaction.
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Scheme 1.

Enzymatic Reactions Catalyzed by FomA and FomB Proteins
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refinement for the MgATP, ATP·fosfomycin, MgADP·FMVO3, MgADP·FM, and ADP structures, respectively. The same Rfree set was used in every case because of the isomorphous character of the data

c
R = Σ‖Fo| − |Fc‖/Σ|Fo|, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively. Rfree is calculated using 1.6, 1.5, 1.5, 1.5, and 1.5% of the reflections omitted from the

Rsym = Σ|Ii − 〈Ii〉|/ΣIi, where Ii is the intensity of the ith observation and 〈Ii〉 is the mean intensity of the reflection.

b

Values in parentheses are for the highest-resolution shell.
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Table 2

Kinetic Data for Wild-Type FomA and FomA Mutants

NIH-PA Author Manuscript

kcat (s−1)

Kmfos (µM)

KmATP (µM)

wild type

9.9 ± 0.7

12.8 ± 1.05

155.9 ± 1.5

S148A

169.8 ± 22.2

42.2 ± 4.2

35.0 ± 2.6

S149A

383.2 ± 45.3

75.5 ± 5.5

14.5 ± 2.2

T210A

NDa

NDa

K9A

23.1 ± 3.1

89.9 ± 11.4

K18A

NDa

NDa

–

H58L

NDa

NDa

–

D208A

17.5 ± 2.5

60.7 ± 5.1

–
4.5 ± 0.3

11.9 ± 0.4

a

No activity detected.
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